drugset / Trial / NCT05278637
GM03 - Platelet RNA Signatures of Aspirin
RandomizedCrossoverOpen-labelBasic science
Summary
This study will involve healthy volunteers and patients with Type 2 diabetes. Eligible healthy volunteers will be invited to enroll into one of two protocols (A or B) and eligible patients with diabetes will be enrolled into protocol A.
Timeline
- Start
- 2013-11-01
- Primary completion
- 2016-12-05
- Completion
- 2016-12-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 81 mg | — |
| Comparator | Aspirin | Small molecule | 325 mg | — |
| Comparator | Ticagrelor | Small molecule | 90 mg | — |